Importer of Controlled Substances; Notice of Application; Rhodes Technologies, 23594 [2013-09305]
Download as PDF
<![CDATA[
23594
Federal Register / Vol. 78, No. 76 / Friday, April 19, 2013 / Notices
applicants for registration to import
basic classes of any controlled substance
in schedules I or II are, and will
By email .. pubcommentcontinue to be, required to demonstrate
ees.enrd@usdoj.gov.
to the Deputy Assistant Administrator,
By mail .... Assistant Attorney General, U.S.
Office of Diversion Control, Drug
DOJ—ENRD, P.O. Box 7611,
Enforcement Administration, that the
Washington, DC 20044–7611.
requirements for such registration
pursuant to 21 U.S.C. 958(a); 21 U.S.C.
During the public comment period,
823(a); and 21 CFR 1301.34(b), (c), (d),
the proposed Decree may be examined
(e), and (f) are satisfied.
and downloaded at this Justice
Department Web site: https://
Dated: April 10, 2013.
www.usdoj.gov/enrd/
Joseph T. Rannazzisi,
Consent_Decrees.html. We will provide Deputy Assistant Administrator, Office of
a paper copy of the proposed Decree
Diversion Control, Drug Enforcement
Administration.
upon written request and payment of
reproduction costs. Please mail your
[FR Doc. 2013–09305 Filed 4–18–13; 8:45 am]
request and payment to:
BILLING CODE 4410–09–P
Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington,
DEPARTMENT OF JUSTICE
DC 20044–7611.
Please enclose a check or money order
Drug Enforcement Administration
for $13.25 (.25 cents per page
reproduction cost) payable to the United Importer of Controlled Substances;
States Treasury.
Notice of Application; Catalent CTS.,
Inc.
Robert Brook,
To submit
comments:
Send them to:
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
Pursuant to Title 21, of the Code of
Federal Regulations 1301.34(a), this is
notice that on August 6, 2012, Catalent
Cts., Inc., 10245 Hickman Mills Drive,
Kansas City, Missouri 64137, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of the
following basic classes of controlled
substances:
[FR Doc. 2013–09203 Filed 4–18–13; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; Rhodes
Technologies
Drug
This is notice that on March 6, 2013,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the following basic classes of controlled
substances:
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with NOTICES
Opium, Raw (9600) ......................
Poppy Straw Concentrate (9670)
II
II
The company plans to import the
listed controlled substances in order to
bulk manufacture controlled substances
in Active Pharmaceutical Ingredient
(API) form. The company distributes the
manufactured APIs in bulk to its
customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
As noted in a previous notice
published in the Federal Register on
September 23, 1975, 40 FR 43745, all
VerDate Mar<15>2010
17:11 Apr 18, 2013
Jkt 229001
I
II
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form, to package for a clinical trial
study. In addition, the company also
plans to import an ointment for the
treatment of wounds which contain
trace amounts of the controlled
substances normally found in poppy
straw concentrate for packaging and
labeling for clinical trials.
Comments and requests for any
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417(2007).
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
Frm 00058
Fmt 4703
Dated: April 10, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–09293 Filed 4–18–13; 8:45 am]
BILLING CODE 4410–09–P
Schedule
Marihuana (7360) .........................
Poppy Straw Concentrate (9670)
PO 00000
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, VA 22152; and must be
filed no later than May 20, 2013.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances,
Notice of Application, Almac Clinical
Services, Inc., (ACSI)
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on March 5, 2013, Almac Clinical
Services, Inc., (ACSI), 25 Fretz Road,
Souderton, Pennsylvania 18964, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
Schedule
II
II
II
II
The company plans to import small
quantities of the listed controlled
substances in dosage form to conduct
clinical trials.
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 78, Number 76 (Friday, April 19, 2013)]
[Notices]
[Page 23594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09305]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application; Rhodes
Technologies
This is notice that on March 6, 2013, Rhodes Technologies, 498
Washington Street, Coventry, Rhode Island 02816, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Opium, Raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
order to bulk manufacture controlled substances in Active
Pharmaceutical Ingredient (API) form. The company distributes the
manufactured APIs in bulk to its customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007).
As noted in a previous notice published in the Federal Register on
September 23, 1975, 40 FR 43745, all applicants for registration to
import basic classes of any controlled substance in schedules I or II
are, and will continue to be, required to demonstrate to the Deputy
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d),
(e), and (f) are satisfied.
Dated: April 10, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-09305 Filed 4-18-13; 8:45 am]
BILLING CODE 4410-09-P
